Sens. Warn Colleagues Not To Derail FDA User Fee Bill
The drug and device industries on Thursday urged a Senate health panel to quickly approve their user fee agreements with the U.S. Food and Drug Administration, as the panel's top members...To view the full article, register now.
Already a subscriber? Click here to view full article